Effect of partial compliance on cardiovascular medication effectiveness

Heart

Volumn 88, Issue 2, 2002, Pages 203-206

  Cramer, Joyce A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COLESTYRAMINE; DOXAZOSIN; GEMFIBROZIL;

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DRUG EFFICACY; HUMAN; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL;

EID: 0036071775     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.88.2.203     Document Type: Article

References (20)

1. Medication compliance: The importance of the dosing regimen
2. How often is medication taken as prescribed? A novel assessment technique
3. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens
4. Medication use by the elderly: Enhancing patient compliance in the elderly: Role of packaging aids and monitoring
5. Consequences of intermittent treatment for hypertension: The case for medication compliance and persistence
6. Compliance with antihypertensive therapy among elderly medicaid enrollees: The roles of age, gender, and race
7. Persistence of use of lipid-lowering medications: A cross-national study
8. Compliance with antihypertensive therapy: A shifting paradigm
9. Compliance declines between clinic visits
10. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project
11. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki heart study
12. Underutilization of antihypertensive drugs and associated hospitalization
13. Electronic compliance monitoring in resistant hypertension: The basis for rational therapeutic decisions
14. A study design for comparing the effects of missing daily doses of antihypertensive drugs
15. Comparison of withdrawal phenomena after propranolol, metroprolol, and pindolol
16. The relative risk of incident coronary heart disease associated with recently stopping use of beta blockers
17. Overview of methods to measure and enhance patient compliance
18. Enhancing medication compliance for people with serious mental illness
19. The multilevel compliance challenge. Recommendations for a call to action: A statement for healthcare professionals
20. How to improve adherence with prescribed treatment in hypertensive patients?